JNJ

Johnson & Johnson Battles St. Jude for Cardiac Mapping Leadership
Motley Fool
Sat, 12/7/13 - 12:56 pm
JNJ
St. Jude Medical
cardiac mapping
What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs
Seeking Alpha
Fri, 12/6/13 - 10:30 am
JNJ
Gilead Sciences
hepatitis C
sofosbuvir
Olysio
AbbVie
Bristol-Myers Squibb
Merck
Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Forbes
Thu, 12/5/13 - 06:45 pm
bloodthinners
Pradaxa
Boehringer Ingelheim
Xarelto
JNJ
Eliquis
Pfizer
Bristol-Myers Squibb
edoxaban
Daiichi Sankyo
J&J Settles FDA Misbranding Case for $1.25 Million
Bloomberg
Thu, 12/5/13 - 08:28 am
FDA
JNJ
misbranding
Advanced Sterilization Products
Sterrad Cyclesure 24
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wed, 12/4/13 - 11:38 am
Bristol-Myers Squibb
GSK
JNJ
Ophthotech
Novartis
Regeneron
Roche
Sanofi
Johnson & Johnson Vs. Pfizer, Bristol In The Race Of Anticoagulants
Seeking Alpha
Tue, 12/3/13 - 11:01 am
JNJ
bloodthinners
Pfizer
Bristol-Myers Squibb
Eliquis
Xarelto
Johnson & Johnson's Real Answer To Imminent Decline In Sales Of Top-Selling Drug
Seeking Alpha
Mon, 12/2/13 - 09:45 am
JNJ
Remicade
Olysio
hepatitis C
J&J May Pay $1 Billion in Medical Costs Under Hip Accord
Bloomberg
Wed, 11/27/13 - 09:05 pm
JNJ
hip implants
DePuy
Keep An Eye On GW, Johnson & Johnson, Durata, and Merck Today
Motley Fool
Wed, 11/27/13 - 09:58 am
JNJ
Durata Therapeutics
Merck
GW Pharma
Olysio
Savitex
Noxafil
Dalvance
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
Milestone payment triggers Genmab guidance increase
Yahoo/Reuters
Tue, 11/26/13 - 09:00 am
Genmab
daratumumab
JNJ
Janssen
EU To Fine J&J And Novartis Over A Pay-To-Delay Deal
Pharmalot
Mon, 11/25/13 - 09:01 am
Europe
JNJ
Novartis
pay-for-delay
generics
Sandoz
Fentanyl
pain patches
J&J, Medivir Win U.S. FDA Approval for Hepatitis C Pill
Bloomberg
Sat, 11/23/13 - 12:49 pm
JNJ
Medvir
hepatitis C
hepatitis
Olysio
simeprevir
J&J Said to Narrow Bidder List to 3 for Diagnostics Business
Bloomberg
Fri, 11/22/13 - 11:01 am
JNJ
M&A
diagnostics
Ortho Clinical Diagnostics
Two Dozen Drugmakers Pay $88M To Louisiana Over Inflated Prices
Pharmalot
Thu, 11/21/13 - 10:11 am
Louisiana
drug pricing
Novartis
Sanofi
JNJ
Par Pharmaceutical
Ranbaxy
Abbott Laboratories
Will Recent News Hurt Johnson & Johnson?
Wall St Cheat Sheet
Thu, 11/21/13 - 08:32 am
JNJ
Vertex Gains on Sale of Drug Rights to Johnson & Johnson Unit
Barron's
Wed, 11/20/13 - 04:37 pm
Vertex Pharmaceuticals
JNJ
Incivo
Janssen
hepatitis C
J&J shares are helped by findings on stroke-prevention medication
Marketwatch
Wed, 11/20/13 - 08:41 am
JNJ
Xarelto
Janssen
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Merck
Humira
apremilast
Enbrel
Stelara
Simponi
Remicade
WSJ: J&J’s hip-implant settlement will be lower than expected
Marketwatch
Tue, 11/19/13 - 12:42 pm
JNJ
hip implants
recalls

Pages